1. Home
  2. CMU vs QNCX Comparison

CMU vs QNCX Comparison

Compare CMU & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFS Municipal Income Trust

CMU

MFS Municipal Income Trust

HOLD

Current Price

$3.50

Market Cap

88.5M

Sector

Finance

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$3.54

Market Cap

139.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMU
QNCX
Founded
1987
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.5M
139.2M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CMU
QNCX
Price
$3.50
$3.54
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.00
AVG Volume (30 Days)
82.4K
1.2M
Earning Date
01-01-0001
11-12-2025
Dividend Yield
4.08%
N/A
EPS Growth
N/A
N/A
EPS
0.07
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$47.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.78
$0.72
52 Week High
$3.38
$4.55

Technical Indicators

Market Signals
Indicator
CMU
QNCX
Relative Strength Index (RSI) 49.20 57.30
Support Level $3.45 $3.74
Resistance Level $3.53 $4.55
Average True Range (ATR) 0.02 0.40
MACD -0.00 -0.08
Stochastic Oscillator 70.00 35.18

Price Performance

Historical Comparison
CMU
QNCX

About CMU MFS Municipal Income Trust

Mfs High Yield Municipal Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes. The company invest various top Healthcare companies, Airport, Universities (Secondary Schools), Universities (Dormitories), and many more, out of maximum revenue is gained from Healthcare Hospitals and Long Term Care.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: